Pakistan as it gets ready to release efficacy results “in a few days" from phase III trials that have recently been completed in the South Asian nation, according to its local partner.The Chinese maker of the single-shot vaccine will be giving Pakistan preferential access and pricing, said Hasan Abbas Zaheer, technical adviser at AJM Pharma Pvt., the local partner.
It has already applied with Pakistan’s drug regulator to get approval.“We need to keep in mind that this coronavirus vaccine is a very scarce commodity, highly in demand and you know the other countries many months ago started the advance booking, we also need to do the same, we are already late on that," said Zaheer in a phone interview.